RNF149 and cancer: Intriguingly, B-RAF and EPHA2 were not included in our candidate list, because B-RAF did not interact with RNF149 based on our Co-IP experiments, and EPHA2 protein levels did not decrease profoundly when RNF149 was overexpressed, which might be resulting from differences of experimental conditions and cancer cell lines.